Business Process Management

WHITE PAPERS AND CASE STUDIES

• Optimizing Charge And N-glycan Profiles For CHO-Derived Fusion Proteins

  Discover how structured design-of-experiment approaches can optimize charge variants and glycosylation to enhance biologics quality and therapeutic performance.

• 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives

  AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

• The Key To Viral Vector Success

  Establishing a robust and scalable viral vector process requires a multidisciplinary approach that incorporates expertise in foundational science, analytics, and biomanufacturing.

• Is The Water Sector Ready For AI?

  Despite AI's potential to transform the water sector, fewer than half of organizations are fully ready for adoption. The biggest challenges are procedural and cultural, like fear of change and workforce readiness. Focus on these internal barriers to gain measurable efficiency and sustainability benefits.

• Don't Let Formulation Failures Derail Drug Development

  In the face of increasing molecular complexity, early developability assessment with a skilled CDMO can reduce pharmaceutical development costs, prevent clinical delays, and improve commercial success.

• Understanding Biosafety Levels

  Compliance with biosafety levels (BSLs) is crucial in ensuring that your laboratories meet stringent standards to protect staff and prevent the escape of biological agents.

• Enhancing Data Capabilities For Greenville Water Utility

  The Greenville Water Utility in Indiana is leveraging Qatium to enhance its water management and leak detection capabilities, significantly improving service efficiency.

• How A Pharma Company Improved Yield By 1.5% In Just Three Months

  A pharma company faced a 4% yield drop and variability at a manufacturing facility. Explore how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.

• Manufacturing Strategies To Industrialize Autologous Therapies

  Discover how a systematic approach to autologous cell therapy manufacturing can reduce costs, improve reliability, and accelerate access to life-changing treatments.

• Why Choose Robotic Processing For Small Batch Aseptic Filling

  Reducing human intervention in aseptic filling is critical for safety and cost efficiency. Learn why automation is essential for small-batch applications and how it’s transforming sterile drug manufacturing.

• 82 Million Gallons In. Zero PFAS Out.

  Ion exchange resin is a reliable, high-capacity solution for municipal PFAS treatment, demonstrating zero detectable PFAS after processing 82 million gallons of water. The technology offers a significantly smaller footprint and superior volumetric capacity compared to GAC. Read the full case study to review performance data and strategic impacts.

• Global e-Consent Matrix

  Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.